![](https://medcitynews.com/wp-content/uploads/sites/7/2023/03/frame_3_No_Box_Bio_Bank-1-2.png)
Perspectum Completes $55M Series C to Improve Metabolic Disease Diagnosis
Perspectum — a company that makes medical imaging devices designed to improve the diagnosis of metabolic diseases and cancer — recently announced the second close of its $55 million Series C funding round. Its flagship product is a diagnostic tool that assesses and monitors chronic liver disease.